Susan Collins said...
Drug development is hamstrung by the fact that we simply do not have well characterized the endpoints for most rare diseases.
Context
Addressing challenges in drug development for rare diseases.
04/04/2022
Addressing challenges in drug development for rare diseases.
04/04/2022